Dentsply Sirona Sees $961M Q4 Revenue, $144M Impairment and 2026 EPS of $1.40–1.50
Dentsply Sirona posted Q4 revenue of $961 million, a 6.2% increase, and took a $144 million non-cash goodwill impairment as full-year sales fell to $3.68 billion with adjusted EBITDA margin at 18.1%. It launched a 24-month growth plan targeting $120 million annual savings and guided 2026 EPS of $1.40–1.50.
1. Q4 Financial Results
Dentsply Sirona delivered fourth-quarter revenue of $961 million, up 6.2% year-over-year, driven by a 370-basis-point foreign-exchange tailwind and favorable prior-year comparisons. Adjusted EBITDA margin was 14.1%, adjusted EPS was $0.27, and the company recorded a $144 million non-cash impairment charge, ending the period with $326 million in cash.
2. Full-Year Performance and Margin
Full-year sales declined to $3.68 billion, while adjusted EBITDA margin expanded to 18.1% thanks to cost controls and efficiency measures. Operating cash flow reached $101 million with $60 million free cash flow, and net debt stood at three times adjusted EBITDA.
3. Return-to-Growth Plan
The 24-month Return-to-Growth plan ramps up R&D and commercial spending, implements a restructuring aimed at unlocking about $120 million in annual savings, and suspends the dividend to prioritize debt reduction and enable future share repurchases.
4. 2026 Outlook and Market Reaction
Management guided 2026 EPS of $1.40–1.50 and anticipates sales of $3.5–3.6 billion with positive momentum in H2, including a $30 million drop-ship inventory sell-through in H1. Shares jumped 13.4% on the revenue beat despite the cautious outlook.